Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 11
Original Research
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,815 | Dovepress* | 9,023+ | 1,567 | 10,590 | |
| PubMed Central* | 1,792 | 684 | 2,476 | ||
| Totals | 10,815 | 2,251 | 13,066 | ||
| *Since 27 November 2018 | |||||
View citations on PubMed Central and Google Scholar